- Beam Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Beam Therapeutics Inc at Citi BioPharma Conference TranscriptSep 07, 2023
- Beam Therapeutics Inc at Stifel Tailoring Genes: Genetic Medicines Day (Virtual) TranscriptMay 30, 2023
- Beam Therapeutics Inc at Barclays Virtual Gene Editing & Therapy Summit TranscriptMay 24, 2023
- Beam Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Beam Therapeutics Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days (Virtual) TranscriptApr 03, 2023
- Beam Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2023
- Beam Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Beam Therapeutics Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Beam Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Beam Therapeutics Inc at Jefferies London Healthcare Conference TranscriptNov 15, 2022
- Beam Therapeutics Inc Annual Shareholders Meeting TranscriptJun 08, 2022
- Beam Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- Beam Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Beam Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2022
- Beam Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Beam Therapeutics Inc at Jefferies Gene Therapy/Editing Summit (Virtual) TranscriptOct 27, 2021
- Beam Therapeutics Inc at Chardan Genetic Medicines Conference (Virtual) TranscriptOct 05, 2021
- Beam Therapeutics Inc at William Blair Biotech Focus Conference (Virtual) TranscriptJul 15, 2021
- Beam Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Beam Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
Beam Therapeutics Inc Annual Shareholders Meeting Transcript
Welcome to the 2022 Annual Stockholders' Meeting of Beam Therapeutics. I will now turn the call over to John Evans, Chief Executive Officer of Beam.
Thank you, and thanks for joining us today. My name is John Evans, and I'm the Chief Executive Officer and a Director of Beam Therapeutics. Beam Therapeutics is a biotechnology company developing precision genetic medicines through a new form of gene editing called base editing. I'm pleased to welcome you to our 2022 Annual Meeting of Stockholders.
We are excited to be hosting our virtual meeting live via webcast, which allows us to be more inclusive and reach a greater number of our stockholders. As a company focused on the development and commercialization of innovative therapies, we view this meeting format as a way to be more efficient in our meeting process, which ultimately benefits all of our shareholders.
Hosting a virtual annual meeting also safely and efficiently facilitates shareholder attendance and participation fully and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)